QUC398

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QUC398, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA [Phase 2]